Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity

Group A streptococcus (GAS) is a global pathogen associated with significant morbidity and mortality for which there is currently no licensed vaccine. Vaccine development has been slow, mostly due to safety concerns regarding streptococcal antigens associated with autoimmunity and related complicati...

Full description

Bibliographic Details
Main Authors: Matthew J. Troese, Elodie Burlet, Madeleine W. Cunningham, Kathy Alvarez, Rebecca Bentley, Nissy Thomas, Shanna Carwell, Garry L. Morefield
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/9/1504
_version_ 1797576504522047488
author Matthew J. Troese
Elodie Burlet
Madeleine W. Cunningham
Kathy Alvarez
Rebecca Bentley
Nissy Thomas
Shanna Carwell
Garry L. Morefield
author_facet Matthew J. Troese
Elodie Burlet
Madeleine W. Cunningham
Kathy Alvarez
Rebecca Bentley
Nissy Thomas
Shanna Carwell
Garry L. Morefield
author_sort Matthew J. Troese
collection DOAJ
description Group A streptococcus (GAS) is a global pathogen associated with significant morbidity and mortality for which there is currently no licensed vaccine. Vaccine development has been slow, mostly due to safety concerns regarding streptococcal antigens associated with autoimmunity and related complications. For a GAS vaccine to be safe, it must be ensured that the antigens used in the vaccine do not elicit an antibody response that can cross-react with host tissues. In this study, we evaluated the safety of our GAS vaccine candidate called VaxiStrep in New Zealand White rabbits. VaxiStrep is a recombinant fusion protein comprised of streptococcal pyrogenic exotoxin A (SpeA) and exotoxin B (SpeB), also known as erythrogenic toxins, adsorbed to an aluminum adjuvant. The vaccine elicited a robust immune response against the two toxins in the rabbits without any adverse events or toxicity. No signs of autoimmune pathology were detected in the rabbits’ brains, hearts, and kidneys via immunohistochemistry, and serum antibodies did not cross-react with cardiac or neuronal tissue proteins associated with rheumatic heart disease or Sydenham chorea (SC). This study further confirms that VaxiStrep does not elicit autoantibodies and is safe to be tested in a first-in-human trial.
first_indexed 2024-03-10T21:52:55Z
format Article
id doaj.art-c9863702893d40238175498b24db68da
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T21:52:55Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-c9863702893d40238175498b24db68da2023-11-19T13:19:53ZengMDPI AGVaccines2076-393X2023-09-01119150410.3390/vaccines11091504Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with AutoimmunityMatthew J. Troese0Elodie Burlet1Madeleine W. Cunningham2Kathy Alvarez3Rebecca Bentley4Nissy Thomas5Shanna Carwell6Garry L. Morefield7VaxForm, LLC., Bethlehem, PA 18015, USAVaxForm, LLC., Bethlehem, PA 18015, USADepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USADepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USADepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USAVaxForm, LLC., Bethlehem, PA 18015, USAVaxForm, LLC., Bethlehem, PA 18015, USAVaxForm, LLC., Bethlehem, PA 18015, USAGroup A streptococcus (GAS) is a global pathogen associated with significant morbidity and mortality for which there is currently no licensed vaccine. Vaccine development has been slow, mostly due to safety concerns regarding streptococcal antigens associated with autoimmunity and related complications. For a GAS vaccine to be safe, it must be ensured that the antigens used in the vaccine do not elicit an antibody response that can cross-react with host tissues. In this study, we evaluated the safety of our GAS vaccine candidate called VaxiStrep in New Zealand White rabbits. VaxiStrep is a recombinant fusion protein comprised of streptococcal pyrogenic exotoxin A (SpeA) and exotoxin B (SpeB), also known as erythrogenic toxins, adsorbed to an aluminum adjuvant. The vaccine elicited a robust immune response against the two toxins in the rabbits without any adverse events or toxicity. No signs of autoimmune pathology were detected in the rabbits’ brains, hearts, and kidneys via immunohistochemistry, and serum antibodies did not cross-react with cardiac or neuronal tissue proteins associated with rheumatic heart disease or Sydenham chorea (SC). This study further confirms that VaxiStrep does not elicit autoantibodies and is safe to be tested in a first-in-human trial.https://www.mdpi.com/2076-393X/11/9/1504Group A Streptococcus (GAS)<i>Streptococcus pyogenes</i>SpeASpeBvaccinesafety
spellingShingle Matthew J. Troese
Elodie Burlet
Madeleine W. Cunningham
Kathy Alvarez
Rebecca Bentley
Nissy Thomas
Shanna Carwell
Garry L. Morefield
Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity
Vaccines
Group A Streptococcus (GAS)
<i>Streptococcus pyogenes</i>
SpeA
SpeB
vaccine
safety
title Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity
title_full Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity
title_fullStr Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity
title_full_unstemmed Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity
title_short Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity
title_sort group a streptococcus vaccine targeting the erythrogenic toxins spea and speb is safe and immunogenic in rabbits and does not induce antibodies associated with autoimmunity
topic Group A Streptococcus (GAS)
<i>Streptococcus pyogenes</i>
SpeA
SpeB
vaccine
safety
url https://www.mdpi.com/2076-393X/11/9/1504
work_keys_str_mv AT matthewjtroese groupastreptococcusvaccinetargetingtheerythrogenictoxinsspeaandspebissafeandimmunogenicinrabbitsanddoesnotinduceantibodiesassociatedwithautoimmunity
AT elodieburlet groupastreptococcusvaccinetargetingtheerythrogenictoxinsspeaandspebissafeandimmunogenicinrabbitsanddoesnotinduceantibodiesassociatedwithautoimmunity
AT madeleinewcunningham groupastreptococcusvaccinetargetingtheerythrogenictoxinsspeaandspebissafeandimmunogenicinrabbitsanddoesnotinduceantibodiesassociatedwithautoimmunity
AT kathyalvarez groupastreptococcusvaccinetargetingtheerythrogenictoxinsspeaandspebissafeandimmunogenicinrabbitsanddoesnotinduceantibodiesassociatedwithautoimmunity
AT rebeccabentley groupastreptococcusvaccinetargetingtheerythrogenictoxinsspeaandspebissafeandimmunogenicinrabbitsanddoesnotinduceantibodiesassociatedwithautoimmunity
AT nissythomas groupastreptococcusvaccinetargetingtheerythrogenictoxinsspeaandspebissafeandimmunogenicinrabbitsanddoesnotinduceantibodiesassociatedwithautoimmunity
AT shannacarwell groupastreptococcusvaccinetargetingtheerythrogenictoxinsspeaandspebissafeandimmunogenicinrabbitsanddoesnotinduceantibodiesassociatedwithautoimmunity
AT garrylmorefield groupastreptococcusvaccinetargetingtheerythrogenictoxinsspeaandspebissafeandimmunogenicinrabbitsanddoesnotinduceantibodiesassociatedwithautoimmunity